These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28351320)

  • 1. Promising therapeutic role of miR-27b in tumor.
    Ding L; Ni J; Yang F; Huang L; Deng H; Wu Y; Ding X; Tang J
    Tumour Biol; 2017 Mar; 39(3):1010428317691657. PubMed ID: 28351320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
    Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
    Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
    Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
    Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
    Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
    Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
    Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa-miR-27b is up-regulated in cytomegalovirus-infected human glioma cells, targets engrailed-2 and inhibits its expression.
    Wang L; Yang M; Liao S; Liu W; Dai G; Wu G; Chen L
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1227-1233. PubMed ID: 28343438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
    Ye J; Wu X; Wu D; Wu P; Ni C; Zhang Z; Chen Z; Qiu F; Xu J; Huang J
    PLoS One; 2013; 8(4):e60687. PubMed ID: 23593282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of microRNA-26a in human cancer progression and clinical application.
    Chen J; Zhang K; Xu Y; Gao Y; Li C; Wang R; Chen L
    Tumour Biol; 2016 Jun; 37(6):7095-108. PubMed ID: 27039398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
    Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
    PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
    Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ
    BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MicroRNA-23b/27b/24 Cluster Facilitates Colon Cancer Cell Migration by Targeting FOXP2.
    Nishida K; Kuwano Y; Rokutan K
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of microRNA-27b promotes retinal pigment epithelial cell proliferation and migration by targeting Nox2.
    Li J; Hui L; Kang Q; Li R
    Pathol Res Pract; 2018 Jul; 214(7):925-933. PubMed ID: 29858119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.
    Eastlack SC; Dong S; Ivan C; Alahari SK
    Mol Cancer; 2018 Jul; 17(1):100. PubMed ID: 30012170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition.
    Yao J; Deng B; Zheng L; Dou L; Guo Y; Guo K
    Oncol Rep; 2016 Mar; 35(3):1645-51. PubMed ID: 26706910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma.
    Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H
    J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of aberrantly expressed microRNAs in prostate cancer.
    Goto Y; Kurozumi A; Enokida H; Ichikawa T; Seki N
    Int J Urol; 2015 Mar; 22(3):242-52. PubMed ID: 25599923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.
    Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance.
    Javanmardi S; Aghamaali MR; Abolmaali SS; Mohammadi S; Tamaddon AM
    Curr Gene Ther; 2017; 16(6):375-389. PubMed ID: 28042781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.